Protagonist Therapeutics (PTGX) Shares Issued (2015 - 2025)
Protagonist Therapeutics (PTGX) posted Shares Issued of $5.3 million for Q4 2025, down 31.57% sequentially from $7.8 million in Q4 2024, and down 31.57% YoY from $7.8 million in Q4 2024.
Protagonist Therapeutics (PTGX) Shares Issued (2015 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Shares Issued for 6 years, with the latest figure at $5.3 million in Q4 2025.
- Quarterly Shares Issued fell 31.57% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (down 31.57% YoY) and the FY2025 annual result came in at $5.3 million, down 31.57% from the prior year.
- Shares Issued retreated to $5.3 million in Q4 2025 per PTGX's latest filing, from $7.8 million in the prior quarter.
- Over five years, Shares Issued peaked at $8.1 million in Q2 2023 and troughed at $114000.0 in Q4 2023.
- A 4-year average of $4.9 million and a median of $4.6 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued tumbled 42.21% in 2023, then soared 6757.15% in 2024.
- Over 4 years, Shares Issued stood at $3.8 million in 2022, then slumped by 96.99% to $114000.0 in 2023, then jumped by 6757.15% to $7.8 million in 2024, then sank by 31.57% to $5.3 million in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $5.3 million, $7.8 million, and $114000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.35 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Jun 30, 2023 | 8.12 Mn |
| Jun 30, 2023 | 8.12 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Mar 31, 2022 | 6.81 Mn |
| Mar 31, 2022 | 6.81 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.30 Mn |
| Jun 30, 2016 | 1.30 Mn |